Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy
Author:
Funder
Key Laboratory of Nuclear Medicine and Molecular Imaging of Sichuan Province
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference46 articles.
1. Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice;Aggarwal;Clin. Cancer Res.,2005
2. The effect of nanoparticle size, shape, and surface chemistry on biological systems;Albanese;Annu. Rev. Biomed. Eng.,2012
3. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy;Alemi;J. Nanobiotechnol.,2018
4. Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues;Almansour;Eur. J. Med. Chem.,2017
5. Design of curcumin-loaded plga nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo;Anand;Biochem. Pharmacol.,2010
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safe, simple and multifunctional hydroxyapatite nanoparticles for efficient overcoming of tumor multidrug resistance;Applied Materials Today;2024-10
2. Biodegradable Polymeric Nanoparticle-Based Drug Delivery Systems: Comprehensive Overview, Perspectives and Challenges;Polymers;2024-09-07
3. Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma;International Journal of Pharmaceutics;2024-08
4. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13
5. QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells;Nanomedicine;2024-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3